Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

B--Notice of Intent to Sole Source

Active
W81XWH12T0353Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The U.S. Army Medical Research Acquisition Activity (USAMRAA) issued a notice on July 17, 2012, indicating its intent to negotiate a sole source contract with Cellular Dynamics International, Inc. (CDI) for customized human induced-pluripotent stem cell (iPSC)-derived neurons. This contract supports the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) in conducting microRNA microarray analysis on human neurons exposed to nerve agents such as soman and VX. CDI is identified as the only responsible source capable of providing the proprietary icell iPSC-derived neurons, which are essential for high-quality, viable, and pure neuronal cell lines necessary to meet the government’s scientific requirements. The selection of CDI is based on their proven ability to produce these cells in large quantities, their previous involvement with related protocols, and their established quality control procedures such as karyotyping. The Government invited capability statements from other potential sources by July 31, 2012, to determine if other technically acceptable products were available, although the government retains sole discretion to proceed without competition if none are deemed suitable. Communication and submissions were to be made electronically to the specified purchasing agent, Kimberly Hannan. This sole source action is conducted in accordance with Federal Acquisition Regulation (FAR) 13.106-1(b), emphasizing the exclusivity of CDI’s technology and the direct relationship between their products and the research mission of USAMRICD.

General Info

USAMRAA intends sole source contract with CDI for proprietary iPSC neurons supporting nerve agent research.

Agency

N/A

NAICS

541711 - Research and Development in Biotechnology

Place of Performance

Not specified

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

1 update
Posted

special-notice

Notice updated

The notice description changed.

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyN/A
ContactsNo contacts available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Notice of Intent to Sole Source 17 July 2012 Notice Type: Intent to Sole Source Date Posted: 17 July 12 Office Address: U.S. Army Medical Research Acquisition Activity ATTN: MCMR-AAA-B 820 Chandler Street, Fort Detrick MD 21702 Tel: +1 (555) 000-0000 EMAIL: contact@example.gov Contact Person: Kimberly Hannan, Purchasing Agent; contact@example.gov Subject: Intent to Sole Source Classification: None Solicitation #: W81XWH12T0353 Set Aside: n/a NOTICE TEXT: The United States Army Medical Acquisition Activity (USAMRAA) intends to negotiate, on a sole source basis, IAW FAR 13.106-1(b) with Cellular Dynamics Intl. Inc, 525 Science Drive Ste 200,Madison WI 53711-1082, as the only responsible source that can provide the customized products needed to fulfill this acquisition. This requirement is in support of USAMRICD's mission to perform microRNA (miRNA) microarray analysis using human neurons exposted to various nerve agents including soman and VX. Using human induced-pluripotent stem cell (iPSC)-derived cell lines is a well established and non-controversial alternative for obtaining large quantities of viable and pure neurons. Cellular Dynamics will provide icell iPSC-derived neurons during a 6-month base period with 5 optional ordering periods throughout a 2-year period. The new protocols are directly related to previous protocols that CDI had supported. Through support of the previous protocols, CDI has knowledge of generating iPSC-derived cells in high quantities to meet the Governments needs and they are both commercially and readily availbale. CDI has previously performed quality control testing via karyotyping to confirm efficiency of cell diferentiation into viable and pure neurons. Adequate knowled on cell viability and purity is central to this study that seeks to fulfill USAMRICD's mission. Icell iPSC-derived neurons are prioprietary products of CDI. All capability statements received by closing of this notification of this synopsis will be considered by the Government. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Based on the above information, the only technically acceptable human iPSC neurons is provided by Cellular Dynamics International. Submit email capability statements (using PDF, MS Word, Excel attachments) to Kimberly Hannan at, contact@example.gov. Email statements are preferred. Statements are due no later than 1:00 P.M. EST on 31 July 2012. No telephone calls will be accepted.

Similar Contracts

Same NAICS industry code

Earlier notices in this NAICS code

Posted before this notice, open and closed

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS